Showing results (81-90 of 138) with videos related to
Sort By:
Pageof 14
Leukemia Research|August 24, 2010
Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 casesSyed J Noor, Wei Tan, Gregory E Wilding, et al.Leukemia & Lymphoma|February 20, 2016
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665Rebecca DeBoer, Gregory Koval, Flora Mulkey, et al.International Journal of Molecular Epidemiology and Genetics|September 28, 2011
XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemiaNataliya Kuptsova-Clarkson, Christine B Ambrosone, Joli Weiss, et al.British Journal of Haematology|July 25, 2015
Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxideDavid Sanford, Francesco Lo-Coco, Miguel A Sanz, et al.International Journal of Cancer|April 27, 2011
Smoking adversely affects survival in acute myeloid leukemia patientsRamya Varadarajan, Andrea S Licht, Andrew J Hyland, et al.Genes, Chromosomes & Cancer|August 5, 2005
Genomic profiling of myeloid sarcoma by array comparative genomic hybridizationGeorge Deeb, Maria R Baer, Daniel P Gaile, et al.The Lancet. Oncology|April 17, 2019
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trialKarim Fizazi, NamPhuong Tran, Luis Fein, et al.Annals of Hematology|September 22, 2011
Is obesity a prognostic factor for acute myeloid leukemia outcome?Hun Ju Lee, Andrea S Licht, Andrew J Hyland, et al.Haematologica|October 8, 2013
Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classificationMeir Wetzler, Krzysztof Mrózek, Jessica Kohlschmidt, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Joseph O Moore, et al.Pageof 14